Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma. [electronic resource]
Producer: 20140514Description: 2409-14 p. digitalISSN:- 1569-8041
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- adverse effects
- Antineoplastic Agents -- adverse effects
- Basic Helix-Loop-Helix Transcription Factors -- biosynthesis
- Biomarkers, Tumor -- metabolism
- Carcinoma, Renal Cell -- drug therapy
- Cell Hypoxia -- drug effects
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Female
- Gene Expression -- drug effects
- Humans
- Hypoxia-Inducible Factor-Proline Dioxygenases -- genetics
- Immunohistochemistry
- Indoles -- adverse effects
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Metastasis
- Prospective Studies
- Pyrroles -- adverse effects
- RNA, Messenger -- biosynthesis
- Sunitinib
- Survival
- Treatment Outcome
- Vascular Endothelial Growth Factor Receptor-3 -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.